EKF Diagnostics Holdings plc (OTCMKTS:EKDHF – Get Free Report) rose 5.4% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.39. Approximately 20,000 shares changed hands during mid-day trading, a decline of 21% from the average daily volume of 25,429 shares. The stock had previously closed at $0.37.
EKF Diagnostics Stock Up 5.4%
The business’s 50 day moving average price is $0.34 and its two-hundred day moving average price is $0.33.
EKF Diagnostics Company Profile
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
See Also
- Five stocks we like better than EKF Diagnostics
- How to Start Investing in Real Estate
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
- How to Invest in Blue Chip Stocks
- Amazon’s Bears Have Raised the White Flag—Get Excited
- What is Short Interest? How to Use It
- Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
